Literature DB >> 14505636

Synthesis of para-alkyl aryl amide analogues of sphingosine-1-phosphate: discovery of potent S1P receptor agonists.

Jeremy J Clemens1, Michael D Davis, Kevin R Lynch, Timothy L Macdonald.   

Abstract

Sphingosine-1-phosphate (S1P) is a biologically active lysophospholipid with the capacity to induce a broad range of cellular responses via its interaction with the S1P family of G-protein coupled receptors. This report describes the synthesis of several potent S1P receptor agonists. For instance, compound 9c displayed an EC(50)=8.6 nM at the S1P(1) receptor using a [gamma-35S]GTP binding assay as compared to an EC(50)=4.5 nM for the endogenous ligand. We also report the effects associated with introduction of a phenyl ring between the 'linker' and 'lipophilic tail' regions of the analogues, for example total loss of activity at S1P(2) and increased agonism at S1P(5).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14505636     DOI: 10.1016/s0960-894x(03)00812-6

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  14 in total

Review 1.  Insights into the pharmacological relevance of lysophospholipid receptors.

Authors:  Tetsuji Mutoh; Richard Rivera; Jerold Chun
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

Review 2.  International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature.

Authors:  Jerold Chun; Timothy Hla; Kevin R Lynch; Sarah Spiegel; Wouter H Moolenaar
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

3.  Synthesis and biological evaluation of gamma-aminophosphonates as potent, subtype-selective sphingosine 1-phosphate receptor agonists and antagonists.

Authors:  Frank W Foss; Ashley H Snyder; Michael D Davis; Michael Rouse; Mark D Okusa; Kevin R Lynch; Timothy L Macdonald
Journal:  Bioorg Med Chem       Date:  2006-11-01       Impact factor: 3.641

4.  Discovery, biological evaluation, and structure-activity relationship of amidine based sphingosine kinase inhibitors.

Authors:  Thomas P Mathews; Andrew J Kennedy; Yugesh Kharel; Perry C Kennedy; Oana Nicoara; Manjula Sunkara; Andrew J Morris; Brian R Wamhoff; Kevin R Lynch; Timothy L Macdonald
Journal:  J Med Chem       Date:  2010-04-08       Impact factor: 7.446

5.  Sphingosine 1-phosphate analogue recognition and selectivity at S1P4 within the endothelial differentiation gene family of receptors.

Authors:  Yuichi Inagaki; Trucchi T Pham; Yuko Fujiwara; Takayuki Kohno; Daniel A Osborne; Yasuyuki Igarashi; Gabor Tigyi; Abby L Parrill
Journal:  Biochem J       Date:  2005-07-01       Impact factor: 3.857

6.  Asymmetric synthesis of conformationally constrained fingolimod analogues--discovery of an orally active sphingosine 1-phosphate receptor type-1 agonist and receptor type-3 antagonist.

Authors:  Ran Zhu; Ashley H Snyder; Yugesh Kharel; Lisa Schaffter; Qin Sun; Perry C Kennedy; Kevin R Lynch; Timothy L Macdonald
Journal:  J Med Chem       Date:  2007-11-10       Impact factor: 7.446

7.  Synthesis and biological evaluation of sphingosine kinase substrates as sphingosine-1-phosphate receptor prodrugs.

Authors:  Frank W Foss; Thomas P Mathews; Yugesh Kharel; Perry C Kennedy; Ashley H Snyder; Michael D Davis; Kevin R Lynch; Timothy L Macdonald
Journal:  Bioorg Med Chem       Date:  2009-04-12       Impact factor: 3.641

Review 8.  Integrating the puzzle pieces: the current atomistic picture of phospholipid-G protein coupled receptor interactions.

Authors:  Abby L Parrill; Gabor Tigyi
Journal:  Biochim Biophys Acta       Date:  2012-09-12

9.  Sphingosine 1-phosphate pKa and binding constants: intramolecular and intermolecular influences.

Authors:  Mor M Naor; Michelle D Walker; James R Van Brocklyn; Gabor Tigyi; Abby L Parrill
Journal:  J Mol Graph Model       Date:  2007-03-14       Impact factor: 2.518

10.  FTY720 story. Its discovery and the following accelerated development of sphingosine 1-phosphate receptor agonists as immunomodulators based on reverse pharmacology.

Authors:  Kunitomo Adachi; Kenji Chiba
Journal:  Perspect Medicin Chem       Date:  2007-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.